Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

SMC Automation AB

Bio Europe intar Stockholm i höst – ”Det svenska ekosystemet tar nu tillfället i akt”

Den internationella life science-konferensen Bio Europe kommer i november för första gången till Sverige. Konferensen, vars program tar inspiration av ABBA-låta...

Vd-byte i Bactiguard

Medicinteknikbolaget Bactiguard har utsett Christine Lind till ny vd. Hon ersätter den tillförordnade vd:n och medgrundaren Thomas von Koch.

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Valves with piezo technology

Efficient control and regulation of gases in medical technology

Svensk vaccinutvecklare får 24 miljoner av brittiskt forskningsprogram

Abera Bioscience får upp till motsvarande cirka 24 miljoner kronor i finansiering från ett brittiskt program inriktat på vacciner som ska stoppa epidemier i låg...

Novo Nordisk gör AI-satsning inom kardiovaskulära sjukdomar

Novo Nordisk förvärvar rättigheterna till ett flertal prekliniska program från amerikanska Valo, ett företag med expertis inom AI-driven läkemedelsutveckling.

Lonza

Coronapandemin påskyndade utveckling av cancervaccin

Coronapandemin gav ett stort uppsving för vaccinfältet. Det vittnar danska biotechbolaget Expres2ion Biotechnologies om, som utvecklar ett vaccin mot bröstcancer.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

Ossiform: Quality control of 3D printed bone implants

Ossiform chose the GOM Scan 1.

Automate E2E Image Analysis Pipelines

ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.

”En väldigt uttalad AI-ångest i samhället idag”

AI kommer mer eller mindre bli en självklarhet på framtidens vårdavdelningar. Det menar Max Gordon, läkaren och AI-experten som forskar på nya applikationer vid...

Eli Lilly to build a USD 2.5-billion plant in Germany

US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.

Vicore tar in en halv miljard inför studie i lungfibros

Vicore Pharma tillförs en halv miljard kronor i en riktad nyemission. Syftet med kapitaltillskottet är att kunna fortsätta utvecklingen av bolagets behandlingar...

CTC Clinical Trial Consultants AB

Origin – En ny serie Skrapvärmeväxlare från SPX FLOW

Origin-serien är utvecklad för att möta förväntningarna från en global marknad i ett produktsegment där skrapvärmeväxlare är bästa tekniska lösning.

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...

Failed to read the fine print – lost his life’s work

A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...

He is zooming in on topical preparations

According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting ap...